Cargando…

Remsima (a Tumor Necrosis Factor (TNF) -α Inhibitor) induced hemolysis in a patient with Crohn's disease - Case report

INTRODUCTION: Crohn's disease (CD) is an idiopathic inflammatory disorder of unknown etiology with genetic, immunologic, and environmental influences. Infliximab is a treatment modality for fistulated Crohn's disease. Infliximab induced hemolysis is rare and very few cases reported before...

Descripción completa

Detalles Bibliográficos
Autores principales:	AL-Ansari, Rehab Y., Khuraim, Arwa AL., Abdalla, Leena, Hamid, Hind, Zakary, N.Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403549/ https://www.ncbi.nlm.nih.gov/pubmed/34484733 http://dx.doi.org/10.1016/j.amsu.2021.102768

Ejemplares similares

Physicochemical characterization of Remsima®
por: Jung, Soon Kwan, et al.
Publicado: (2014)

Glycosylation profile and biological activity of Remicade® compared with Flixabi® and Remsima®
por: Lee, Changsoo, et al.
Publicado: (2017)

Coronavirus disease 2019 (COVID-19) in special groups: A single-center experience in sickle cell disease patients in Saudi Arabia
por: Al-Ansari, Rehab Y., et al.
Publicado: (2022)

Isolated ten-eleven translocation 2 positive in triple negative essential thrombocythemia: Case report and literature review
por: AL-Ansari, Rehab Y, et al.
Publicado: (2021)

The Budget Impact of Biosimilar Infliximab (Remsima(®)) for the Treatment of Autoimmune Diseases in Five European Countries
por: Jha, Ashok, et al.
Publicado: (2015)

Best management modality of trichobezoar: A case report
por: Al-Osail, Emad M., et al.
Publicado: (2018)

Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn's Disease
por: Fonseca, Ashley, et al.
Publicado: (2021)

Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade(®) to Remsima(®)? An Observational Study
por: Xue, Laixi, et al.
Publicado: (2020)

Real-world data on the infliximab biosimilar CT-P13 (Remsima(®)) in inflammatory bowel disease
por: Huguet, Jose María, et al.
Publicado: (2021)

Systematic review and meta-analysis on the association of tuberculosis in Crohn’s disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα)
por: Cao, Brent L, et al.
Publicado: (2018)

Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-α) Agents in Crohn’s Disease
por: Kim, Sun, et al.
Publicado: (2021)

Initiation of subcutaneous infliximab (Remsima) therapy for the treatment of inflammatory bowel disease during the COVID-19 pandemic
por: McGoran, John, et al.
Publicado: (2021)

Impending splenic rupture as indicator of atypical chronic lymphocytic leukemia: A case report from Saudi Arabia
por: Al-Ansari, Rehab Y., et al.
Publicado: (2023)

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
por: Jang, Dan-in, et al.
Publicado: (2021)

Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease
por: Kamel, Amir Y., et al.
Publicado: (2016)

Evaluation of the physicochemical and functional stability of diluted REMSIMA(®) upon extended storage—A study compliant with NHS (UK) guidance
por: Young, Benjamin L., et al.
Publicado: (2015)

Molecular docking analysis of natural compounds as TNF-α inhibitors for Crohn's disease management
por: Moawadh, Mamdoh S
Publicado: (2023)

The TNF-α -308 polymorphism may affect the severity of Crohn's disease
por: Santana, Genoile, et al.
Publicado: (2011)

Regulatory T cells in Crohn's disease following anti‐TNF‐α therapy
por: Chiba, Toshimi, et al.
Publicado: (2019)

ABO in Correlation to the Requirement of Mechanical Ventilation and Mortality in Critically Ill Patients With COVID-19
por: Al-Ansari, Rehab Y., et al.
Publicado: (2021)

Ceramide Kinase Regulates the Production of Tumor Necrosis Factor α (TNFα) via Inhibition of TNFα-converting Enzyme
por: Lamour, Nadia F., et al.
Publicado: (2011)

Genetic polymorphisms in tumour necrosis factor receptors (TNFRSF1A/1B) illustrate differential treatment response to TNFα inhibitors in patients with Crohn’s disease
por: Qasem, Ahmad, et al.
Publicado: (2019)

Intestinal-Specific TNFα Overexpression Induces Crohn’s-Like Ileitis in Mice
por: Bamias, Giorgos, et al.
Publicado: (2013)

Tumour necrosis factor-alpha (TNFα) stimulates the growth of human bone marrow stromal cells
por: Rougier, F., et al.
Publicado: (1997)

The ex vivo production of tumor necrosis factor-α (TNF-α) in men: relationship to cytokine balance during cardiopulmonary bypass
por: Tabardel, Y, et al.
Publicado: (2000)

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro
por: Tchorzewski, H., et al.
Publicado: (1993)

Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
por: Yu, Jongwook, et al.
Publicado: (2022)

Tumor necrosis factor-α, TNF receptor, and soluble TNF receptor responses to aerobic exercise in the heat
por: Arroyo, Eliott, et al.
Publicado: (2020)

Pulmonary Tuberculosis After Therapy with Anti-Tumor Necrosis Factor (TNF) for Crohn Disease: A Case Report
por: da Silva, Douglas Inomata Cardoso, et al.
Publicado: (2021)

Smoking Induced Hemolysis: Spectral and microscopic investigations
por: Masilamani, Vadivel, et al.
Publicado: (2016)

Anti-TNF Therapy in Crohn’s Disease
por: Adegbola, Samuel O., et al.
Publicado: (2018)

Paradoxical SAPHO syndrome observed during anti-TNFα therapy for Crohn’s disease
por: Amano, Hitoshi, et al.
Publicado: (2017)

TNFα Induces LGR5+ Stem Cell Dysfunction In Patients With Crohn’s Disease
por: Lee, Chansu, et al.
Publicado: (2021)

In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells
por: Hölttä, Veera, et al.
Publicado: (2012)

Tumour Necrosis Factor Alpha (TNF-α) and Oral Squamous Cell Carcinoma
por: Brierly, Gary, et al.
Publicado: (2023)

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Effects of visceral adipose tissue on anti-tumour necrosis factor-α in Crohn’s disease
por: Li, Kangrong, et al.
Publicado: (2023)

TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients
por: Al-Rayes, Hannan, et al.
Publicado: (2011)

Prognostic value of the hemolysis index in patients with significant hemolysis
por: Cortés, Diego O, et al.
Publicado: (2015)

The impact of metallothionein-II on microglial response to tumor necrosis factor-alpha (TNFα) and downstream effects on neuronal regeneration
por: Leung, Jacqueline Y. K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qiv7ndum4cevj8jstibrldv2t8